Drug
5 Fluorouracil 4
5 Fluorouracil 4: highest development phase Post-Market, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| 5-fluorouracil 4% (Tolak) NCT04875026 | Post-Market | Actinic Keratoses |
Latest
No recent events.
Follow 5 Fluorouracil 4 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.